This information was published on 2025-05-04T00:08:22 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2523773 (IR 1839701) |
| (220) |
10 Jan 2025
|
| (300) |
FR, 03 Dec 2024, 5102522
|
| (511) (510) |
Class 5
Pharmaceutical products for prevention and treatment of cardio-metabolic diseases. |
| (540) | ONJOLCEV |
| (550) | Word |
| (730) |
BIOFARMA
|
Find out more about publications on the About page.